07:00 , Apr 7, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Autoimmune disease Osteoarthritis (OA) ADAM metallopeptidase with thrombospondin type 1 motif 4 (ADAMTS4); ADAMTS5 In vitro and rat studies identified a series of selective aggrecanase...
07:00 , Jun 3, 2010 |  BC Innovations  |  Cover Story

HIF2A: mastering osteoarthritis

Most approved osteoarthritis therapies treat symptoms of the disease but not the underlying processes that lead to cartilage destruction and bone spur formation in joints. Now, separate research teams from Japan and South Korea have...